These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 20861457)

  • 41. Positive crosstalk between EGFR and the TF-PAR2 pathway mediates resistance to cisplatin and poor survival in cervical cancer.
    Hugo de Almeida V; Guimarães IDS; Almendra LR; Rondon AMR; Tilli TM; de Melo AC; Sternberg C; Monteiro RQ
    Oncotarget; 2018 Jul; 9(55):30594-30609. PubMed ID: 30093972
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Investigation of the Filamin A-Dependent Mechanisms of Tissue Factor Incorporation into Microvesicles.
    Collier MEW; Ettelaie C; Goult BT; Maraveyas A; Goodall AH
    Thromb Haemost; 2017 Nov; 117(11):2034-2044. PubMed ID: 29044292
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activation of PAR2 or/and TLR4 promotes SW620 cell proliferation and migration via phosphorylation of ERK1/2.
    Zhou B; Zhou H; Ling S; Guo D; Yan Y; Zhou F; Wu Y
    Oncol Rep; 2011 Feb; 25(2):503-11. PubMed ID: 21152870
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The expression and the functional roles of tissue factor and protease-activated receptor-2 on SW620 cells.
    Zhou H; Hu H; Shi W; Ling S; Wang T; Wang H
    Oncol Rep; 2008 Nov; 20(5):1069-76. PubMed ID: 18949403
    [TBL] [Abstract][Full Text] [Related]  

  • 45. EPCR-dependent PAR2 activation by the blood coagulation initiation complex regulates LPS-triggered interferon responses in mice.
    Liang HP; Kerschen EJ; Hernandez I; Basu S; Zogg M; Botros F; Jia S; Hessner MJ; Griffin JH; Ruf W; Weiler H
    Blood; 2015 Apr; 125(18):2845-54. PubMed ID: 25733582
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tissue factor and glycoprotein C on herpes simplex virus type 1 are protease-activated receptor 2 cofactors that enhance infection.
    Sutherland MR; Ruf W; Pryzdial EL
    Blood; 2012 Apr; 119(15):3638-45. PubMed ID: 22374699
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protease-activated receptor 2 (PAR2) mediates vascular smooth muscle cell migration induced by tissue factor/factor VIIa complex.
    Marutsuka K; Hatakeyama K; Sato Y; Yamashita A; Sumiyoshi A; Asada Y
    Thromb Res; 2002 Sep; 107(5):271-6. PubMed ID: 12479889
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular dynamics simulations and functional characterization of the interactions of the PAR2 ectodomain with factor VIIa.
    Zhang Q; Petersen HH; Ostergaard H; Ruf W; Olson AJ
    Proteins; 2009 Nov; 77(3):559-69. PubMed ID: 19536895
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protease-activated receptor 2 promotes actomyosin dependent transforming microvesicles generation from human breast cancer.
    Das K; Prasad R; Singh A; Bhattacharya A; Roy A; Mallik S; Mukherjee A; Sen P
    Mol Carcinog; 2018 Dec; 57(12):1707-1722. PubMed ID: 30129687
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activation of β1 integrins and caveolin-1 by TF/FVIIa promotes IGF-1R signaling and cell survival.
    Åberg M; Edén D; Siegbahn A
    Apoptosis; 2020 Aug; 25(7-8):519-534. PubMed ID: 32458278
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Protease- and cell type-specific activation of protease-activated receptor 2 in cutaneous inflammation.
    Fleischer MI; Röhrig N; Raker VK; Springer J; Becker D; Ritz S; Bros M; Stege H; Haist M; Grabbe S; Haub J; Becker C; Reyda S; Disse J; Schmidt T; Mahnke K; Weiler H; Ruf W; Steinbrink K
    J Thromb Haemost; 2022 Dec; 20(12):2823-2836. PubMed ID: 36161697
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation.
    Bromberg ME; Konigsberg WH; Madison JF; Pawashe A; Garen A
    Proc Natl Acad Sci U S A; 1995 Aug; 92(18):8205-9. PubMed ID: 7667269
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Filamin-A is required for the incorporation of tissue factor into cell-derived microvesicles.
    Collier ME; Maraveyas A; Ettelaie C
    Thromb Haemost; 2014 Apr; 111(4):647-55. PubMed ID: 24258684
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tissue Factor/ FVIIa prevents the extrinsic pathway of apoptosis by regulation of the tumor suppressor Death-Associated Protein Kinase 1 (DAPK1).
    Aberg M; Johnell M; Wickström M; Siegbahn A
    Thromb Res; 2011 Feb; 127(2):141-8. PubMed ID: 21168190
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activation of PAR2 by tissue factor induces the release of the PTEN from MAGI proteins and regulates PTEN and Akt activities.
    Mohammad MA; Greenman J; Maraveyas A; Ettelaie C
    Sci Rep; 2020 Dec; 10(1):20908. PubMed ID: 33262514
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The relationship between tissue factor and cancer progression: insights from bench and bedside.
    van den Berg YW; Osanto S; Reitsma PH; Versteeg HH
    Blood; 2012 Jan; 119(4):924-32. PubMed ID: 22065595
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tissue factor--a receptor involved in the control of cellular properties, including angiogenesis.
    Chen J; Bierhaus A; Schiekofer S; Andrassy M; Chen B; Stern DM; Nawroth PP
    Thromb Haemost; 2001 Jul; 86(1):334-45. PubMed ID: 11487022
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regulation of tissue factor-induced signaling by endogenous and recombinant tissue factor pathway inhibitor 1.
    Ahamed J; Belting M; Ruf W
    Blood; 2005 Mar; 105(6):2384-91. PubMed ID: 15550483
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PAR2-Induced Tissue Factor Synthesis by Primary Cultures of Human Kidney Tubular Epithelial Cells Is Modified by Glucose Availability.
    Humphries TLR; Shen K; Iyer A; Johnson DW; Gobe GC; Nikolic-Paterson D; Fairlie DP; Vesey DA
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299151
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tissue factor as an effector of angiogenesis and tumor progression in hematological malignancies.
    López-Pedrera C; Barbarroja N; Dorado G; Siendones E; Velasco F
    Leukemia; 2006 Aug; 20(8):1331-40. PubMed ID: 16728982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.